{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "ORPHAN DRUG" in comments (approximate match)
Status:
Investigational
Source:
NCT01230801: Phase 1/Phase 2 Interventional Completed Pompe Disease
(2011)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03739606: Phase 2 Interventional Withdrawn Acute Biphenotypic Leukemia
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04396717: Phase 1 Interventional Completed Malignant Primary Brain Tumors
(2021)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01098266: Phase 3 Interventional Completed Malignant Pleural Mesothelioma
(2010)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01995188: Phase 1 Interventional Completed Non-Squamous Non-Small Cell Lung Cancer
(2013)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01627002: Phase 1 Interventional Terminated Healthy Volunteers
(2012)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01647828: Phase 1/Phase 2 Interventional Completed Stage IV Pancreatic Cancer
(2012)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03057795: Phase 2 Interventional Active, not recruiting Classic Hodgkin Lymphoma
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01794663: Phase 2 Interventional Completed Delayed Graft Function
(2012)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00354926: Phase 1 Interventional Completed Non-Hodgkin's Lymphoma
(2006)
Source URL:
Class:
PROTEIN
